Navigation Links
Genetic testing for new warfarin patients is rare, but often inappropriate
Date:4/18/2012

SAN FRANCISCO, April 18, 2012 /PRNewswire/ -- Genetic testing to determine a more accurate initial dosing of warfarin, a drug used to prevent blood clots, remains rare, but is often done for inappropriate patients, according to a new study by Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM). The study will be presented on Friday, April 20, at the Academy of Managed Care Pharmacy (AMCP)'s 24th Annual Meeting & Expo in San Francisco.

The study found that genetic testing associated with warfarin is being performed at a rate of only 4 per 100 individuals, consistent with 2012 American College of Chest Physician guidelines which recommended against routine testing. Despite its rare use, nearly two-thirds of those patients on warfarin who received a genetic test were tested inappropriately, typically those who have already been on the drug for five days or more.

"Based on the increased prevalence of genetic testing, it is clear health plans need to ensure the right member is tested at the right time for the best outcomes," said Patrick Gleason, PharmD, director of clinical outcomes assessment at Prime. "Genetic testing for patients taking warfarin remains controversial and this study shows that while testing is rare, a large number of those being tested are not tested appropriately."

To identify warfarin genetic testing prevalence, appropriateness and cost, researchers from Prime in collaboration with Blue Cross and Blue Shield of Minnesota (BCBSM), reviewed integrated pharmacy and medical claims data from a 1.2 million member commercially insured population. This study emphasizes the value of health plan and PBM collaboration since combining medical and pharmacy data allows for comprehensive assessment of drug safety, effectiveness and total cost of care that ensures clinical pharmacy decisions reflect a complete view of utilization and costs.

There were 8,396 unique members with a warfarin claim during the stu
'/>"/>

SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Genetics Determine Optimal Drug Dose of Common Anticoagulant
4. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
5. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
6. Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products
7. 454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities
11. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... -- Dr. Mark Rasak , MD is recognized by ... in the field of Medicine as a result of ... Dr. Rasak has over 15 years of experience ... business; overseeing the daily operations; interventional cardiology; complex coronary ... he is an honored Fellow of the American Board ...
(Date:8/22/2014)... , Cali ., Aug. 22, 2014 /PRNewswire/ ... Conference shows that a therapy being developed by Hera Therapeutics ... that cause 70 percent of all cervical cancer. ... the replication of HPV-16, HPV-18 and HPV-11 cells, according to ... , Ph.D., who presented the findings at the ...
(Date:8/22/2014)... , Aug. 22, 2014 /PRNewswire/ - SQI ... that develops and commercializes proprietary technologies and products ... has entered into a Master Service Agreement to ... DNA-based pathogen detection assays. During the initial phase ... deliver an automated working prototype of one of ...
Breaking Medicine Technology:Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3
... 16, 2011 The largest human dermal allograft available on ... be introduced at the AWR meeting here this week.  The ... introducing FlexHD acellular hydrated dermal matrix 20 cm ... x 25 cm grafts. FlexHD large ...
... June 16, 2011 Reata Pharmaceuticals , Inc. and ... clinical trial to evaluate the safety and efficacy of bardoxolone methyl ... and type 2 diabetes. The trial, known as BEACON ... with C hronic kidney disease and type 2 diabetes: the ...
Cached Medicine Technology:Largest Acellular Dermal Allografts Available for Abdominal Wall Reconstruction Introduced at AWR 2011 2Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes 2Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes 3
(Date:8/22/2014)... UK (PRWEB) August 22, 2014 The ... recent past, specifically in the developing world, has led ... and the number of deaths due to AIDS globally. ... declining, the number of new patients becoming affected by ... conscious efforts being undertaken by all related organisations and ...
(Date:8/22/2014)... Ohio (PRWEB) August 22, 2014 Dayton Children's ... care tower as part of a $141 million campus renewal. ... patient care tower were unveiled to the public. , ... facilities plan that will create a campus that meets the ... future. These new care spaces will embody Dayton Children’s unique ...
(Date:8/22/2014)... PA (PRWEB) August 22, 2014 Menstrual ... An inventor from Sunrise, Fla., decided that there needed ... , Easy to use and producible in design variations, ... stains caused by leaks, which avoids embarrassment and promotes ... to conventional sanitary pads. , The original design was ...
(Date:8/22/2014)... 22, 2014 (HealthDay News) -- Many children get anxious ... but there are a number of ways that parents ... expert suggests. The first step is to explain ... help protect their health, said Rita John, director of ... University School of Nursing in New York City. ...
(Date:8/22/2014)... Cleveland, Ohio (PRWEB) August 22, 2014 A ... the mood-food connection. The summit is no-cost and open ... their best kept secrets, practical tips and advice on how ... to lose or manage weight. Mindful eating is not ... decisions and stay motivated instead of an "eat this, don't ...
Breaking Medicine News(10 mins):Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 2Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 4Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 5Health News:Simple Steps Make Shots Less Scary for Kids, Nurse Says 2Health News:20 Top Experts Discuss How to Unravel the Food-Mood Connection 2
... Golf can be a good investment for the health, according ... Institutet. The death rate for golfers is 40 per cent ... and socioeconomic status, which correspond to a 5 year increase ... safest. , It is a well-known fact that exercise ...
... 2008) Results from a pivotal Phase III ... oral, once-daily, investigational anticoagulant medication, was superior in ... total knee replacement (TKR) surgery. The head-to-head study ... enoxaparin, the current standard of care. , Data ...
... May 30 Lutronic, Inc., one of,the world,s ... today that its MOSAIC eCO2 system, the next ... the deep,ablative features of a CO2 laser, is ... With intuitive touch-screen software, the powerful MOSAIC ...
... May 30 /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. ... been notified by,the American Stock Exchange (the "AMEX") ... for regaining compliance with the continued listing,standards and ... stock from the,Exchange by filing a delisting application ...
... less likely than white women to receive the radiation ... according to a study that Dana-Farber Cancer Institute researchers ... Society of Clinical Oncology in Chicago. , Although the ... that thousands of black and Hispanic breast cancer patients ...
... COLUMBUS, Ohio Medical researchers at The Ohio State ... a $34 million grant from the National Institutes of ... translational protocols that help identify and advance treatments for ... received by Ohio State. , The Ohio State University ...
Cached Medicine News:Health News:Golf prolongs life 2Health News:Rivaroxaban phase III pivotal data presented at EFORT annual meeting 2Health News:Rivaroxaban phase III pivotal data presented at EFORT annual meeting 3Health News:Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use 2Health News:Soon to Be Released: Lutronic Announces the MOSAIC eCO2, the World's First 'Smart' Fractional CO2 Laser System for Treating Aesthetic and Dermatological Conditions, Will Soon Be Coming to the U.S. Market for Commercial Use 3Health News:Delisting Notification Received from the American Stock Exchange 2Health News:Blacks, Hispanics less likely than whites to receive follow-up radiation for early breast cancer 2Health News:Ohio State receives $34M NIH grant 2
... developed to create physically secured rooms that ... are converted to RFID portals. These Intelli-Storeroom™ ... antennas by VerdaSee's Field Engineering experts. RFID ... that are to be tracked. The assets ...
... enabled Med Station provides a real time ... during anesthesia. The portable workstation automatically tracks ... removed. The system automatically reorders product from ... tracks expiration dates, catalog numbers and lot ...
... VerdaSee Location-ID™ is a family ... track equipment and individuals inside hospitals, ... radio frequency technology. The target tracking ... through a series of radio frequency ...
Assetrac allows identification, location, and protection of your assets....
Medicine Products: